• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Azurity Pharmaceuticals Acquires Slayback Pharma

    PR NEWSWIRE

    Slayback`s Generic Baclofen Receives Approval in the U.S.

    FDA

    Slayback`s Generic Brimonidine Tartrate Receives Tentative Approval in U.S.

    FDA

    Slayback Pharma`s Generic Methylprednisolone Acetate Receives Approval in U.S.

    FDA

    Slayback`s Generic Formoterol Fumarate Receives Approval in the U.S.

    FDA

    Slayback`s Generic Arformoterol Tartrate Receives Approval in the U.S.

    FDA

    Dr. Reddy`s Laboratories enters into a licensing agreement with Slayback Pharma

    BUSINESSWIRE

    Pfizer Sues Teva, Slayback to Block Copies of Two Xeljanz Doses

    BLOOMBERGLAW

    Slayback Appoints Pete Meyers as Chief Financial Officer

    PR NEWSWIRE

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.